Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
BiomX ( (PHGE) ) has provided an update.
On March 25, 2026, BiomX received a notice from NYSE American stating it was not in compliance with multiple continued listing standards because its stockholders’ equity fell below required minimums after several years of net losses. The company, which is ineligible for available exemptions, must submit a remediation plan by April 24, 2026, and regain compliance by September 25, 2027, or face potential delisting, although trading of its shares under the symbol PHGE continues for now.
The notice does not immediately affect BiomX’s operations or SEC reporting obligations, and management is evaluating options to address the equity shortfall and intends to file a plan within the exchange’s deadline. In a related financial red flag, the company’s 2025 audit opinion, disclosed on February 19, 2026, contained a going concern qualification, underscoring ongoing liquidity and viability concerns for investors and other stakeholders.
The most recent analyst rating on (PHGE) stock is a Sell with a $5.00 price target. To see the full list of analyst forecasts on BiomX stock, see the PHGE Stock Forecast page.
Spark’s Take on PHGE Stock
According to Spark, TipRanks’ AI Analyst, PHGE is a Neutral.
The score is primarily held down by weak financial performance (no revenue, persistent losses, and ongoing cash burn with a limited runway and negative equity). Technical signals are mixed and only modestly supportive. Valuation is not compelling given the negative P/E and lack of dividend support, while the earnings call and recent corporate actions provide some offset via clinical/regulatory progress and financing steps but carry notable execution and dilution risks.
To see Spark’s full report on PHGE stock, click here.
More about BiomX
BiomX Inc., based in Netanya, Israel, is a publicly traded company listed on the NYSE American under the ticker PHGE. The company operates in the biotechnology sector, and its financial condition has recently drawn regulatory scrutiny as recurring losses have eroded its stockholders’ equity to levels below the exchange’s continued listing thresholds.
Average Trading Volume: 1,017,038
Technical Sentiment Signal: Strong Sell
Current Market Cap: $7.51M
See more data about PHGE stock on TipRanks’ Stock Analysis page.